期刊文献+

临床路径应用于精神分裂症患者的Meta分析 被引量:6

The application of clinical pathways on patients with schizophrenia:a meta-analysis
下载PDF
导出
摘要 目的采用偱证医学Meta分析的方法以探讨临床路径对精神分裂症患者临床诊疗的影响。方法计算机检索中文数据库,全面收集有关国内临床路径对精神分裂症患者临床诊疗的影响临床对照研究,汇总数据采用RevMan5.1.6和STATA10.0进行分析,两组之间差异采用标准均数差(standardized mean difference,SMD)或优势比(oddsratio,OR)及其95%可信区间(95%confidence interval,95%CI)描述。结果严格根据纳入和排除标准,最终纳入5个临床对照研究,包括429例精神分裂症患者,其中观察组213例,对照组216例。Meta分析结果表明:临床路径组的平均住院时间、平均住院费用及患者满意度与对照组相比均有明显统计学差异(均P<0.05)。结论临床路径作为提高医疗护理质量、降低医疗护理费用的一种新的管理模式,在临床上值得推广应用。 Objective To investigate the effects of clinical pathway management applied on schizophrenics by conducted a systematic review and meta-analysis.Methods WanFang,CNKI,VIP and CBM databases were searched extensively to identify relevant clinical controlled trials.Data were analyzed by RevMan 5.1.6 and STATA 10.0 softwares.Results were described as Standardized mean difference (SMD)or odds ratio (OR) with 95% confidence intervals (CI).Results Finally,a total of 3 clinical controlled trials involving 208 schizophrenia were included in this systematic review,including 105 patients in observation group and 103 patients in control group.Meta-analysis showed that there were statistically significant differences in patients' average length of hospital stay (P0.05),average hospital costs (P0.05) and patient satisfaction (P0.05).Conclusion The results of this study showed that the clinical pathway used on patients with schizophrenia,could significantly shorten the average length of stay,reduce hospital costs,improve medical care and nursing service quality and patients'and their families'cognitive ability to the disease and satisfaction to nursing action,relieve or improve patients'psychiatric symptoms effectively at the same time,promoting patients'rehabilitation.Clinical pathways,as a new model of management,should be applied widely to improve health care quality and reduce medical care costs in clinical practice.
作者 周春香 田慧
出处 《中国老年保健医学》 2012年第6期34-37,共4页 Chinese Journal of Geriatric Care
关键词 临床路径 精神分裂症 临床对照研究 META分析 clinical pathways schizophrenia clinical controlled trials meta-analysis
  • 相关文献

参考文献28

二级参考文献87

共引文献309

同被引文献57

  • 1汪栋祥,江开达,钱伊萍,张野,禹顺英,江三多.伴精神病性症状的双相情感障碍与MA0基因关联分析[J].中国民康医学,2005,17(9):481-484. 被引量:3
  • 2李捷伟,龚纯贵.利用临床路径推进合理用药[J].中华医院管理杂志,2006,22(4):235-236. 被引量:35
  • 3王永炎,鲁兆麟.中医内科学[M].2版.北京:人民卫生出版社,2011:347-356.
  • 4董军,李军,周亚春,等.临床路径信息系统设计与应用[C].中华医院信息网络大会暨中美医院信息化论坛论文集,2006:5.
  • 5袁剑云,英立平.临床路径实施手册[M].北京:北京医科大学出版社.2002:8-13.
  • 6张明同.精神科评定量表手册[M].2版.长沙:湖南科学技术出版社.2003:81-94.
  • 7Campbel H,Hotchkiss R,BradshawN,et al. Integrated care pathways [ J ]. BMJ,1998,316(7125) :13 -157.
  • 8Coffey R J,Richards J S, RemmertCS, et al. An introduction to critical path [ J ].Qual Manag Health Care, 2005 , 14 ( 1 ) : 46 -55.
  • 9Van Herck P,Vanhaecht K,Deneck-ere S, et al. Key interventions and outcomes injoint arthroplasty clinical pathways : a systematicreview[ J]. J Eval Clin Pract, 2010,16(1) :39-49.
  • 10范尚冬.国际精神与行为障碍分类第10版(ICD - 10)临床描述与诊断要点[M].北京:人民卫生出版社,1993:40-106.

引证文献6

二级引证文献33

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部